178 related articles for article (PubMed ID: 16007683)
1. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma.
Ficarra V; Schips L; Guillè F; Li G; De La Taille A; Prayer Galetti T; Cindolo L; Novara G; Zigeuner RE; Bratti E; Tostain J; Altieri V; Abbou CC; Artibani W; Patard JJ
Cancer; 2005 Sep; 104(5):968-74. PubMed ID: 16007683
[TBL] [Abstract][Full Text] [Related]
2. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
Ficarra V; Novara G; Galfano A; Novella G; Schiavone D; Artibani W
Urology; 2004 Jun; 63(6):1050-4. PubMed ID: 15183948
[TBL] [Abstract][Full Text] [Related]
3. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
[TBL] [Abstract][Full Text] [Related]
4. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
[TBL] [Abstract][Full Text] [Related]
6. Proposal for revision of the TNM classification system for renal cell carcinoma.
Ficarra V; Guillè F; Schips L; de la Taille A; Prayer Galetti T; Tostain J; Cindolo L; Novara G; Zigeuner R; Bratti E; Li G; Altieri V; Abbou CC; Zanolla L; Artibani W; Patard JJ
Cancer; 2005 Nov; 104(10):2116-23. PubMed ID: 16208703
[TBL] [Abstract][Full Text] [Related]
7. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
Carini M; Minervini A; Lapini A; Masieri L; Serni S
J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review.
Herrmann E; Trojan L; Becker F; Wülfing C; Schrader AJ; Barth P; Stöckle M; Hammerschmied CG; Staehler M; Stief C; Haferkamp A; Hohenfellner M; Legal W; Wullich B; Bolenz C; Klein T; Noldus J; Bierer S; Hertle L; Brenner W; Roos F; Michel MS; Walter B; Wieland W; Gerss J; Otto W; Hartmann A
J Urol; 2010 Feb; 183(2):460-6. PubMed ID: 20006851
[TBL] [Abstract][Full Text] [Related]
9. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.
Frank I; Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
J Urol; 2005 Jun; 173(6):1889-92. PubMed ID: 15879769
[TBL] [Abstract][Full Text] [Related]
10. Reassessing the current TNM lymph node staging for renal cell carcinoma.
Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR
Eur Urol; 2006 Feb; 49(2):324-31. PubMed ID: 16386352
[TBL] [Abstract][Full Text] [Related]
11. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
[TBL] [Abstract][Full Text] [Related]
12. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED
Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740
[TBL] [Abstract][Full Text] [Related]
13. Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma.
Minervini A; Serni S; Tuccio A; Siena G; Vittori G; Masieri L; Giancane S; Lanciotti M; Khorrami S; Lapini A; Carini M
Ann Surg Oncol; 2012 Feb; 19(2):694-700. PubMed ID: 21861225
[TBL] [Abstract][Full Text] [Related]
14. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.
Lambert EH; Pierorazio PM; Shabsigh A; Olsson CA; Benson MC; McKiernan JM
Urology; 2007 Jun; 69(6):1054-8. PubMed ID: 17572185
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
[TBL] [Abstract][Full Text] [Related]
16. External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma.
Ku JH; Moon KC; Kwak C; Kim HH
Urology; 2009 Aug; 74(2):359-63. PubMed ID: 19501879
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
18. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors.
Moch H; Gasser T; Amin MB; Torhorst J; Sauter G; Mihatsch MJ
Cancer; 2000 Aug; 89(3):604-14. PubMed ID: 10931460
[TBL] [Abstract][Full Text] [Related]
19. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma.
Jeong IG; Jeong CW; Hong SK; Kwak C; Lee E; Lee SE
Urology; 2006 Apr; 67(4):709-12. PubMed ID: 16566981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
